PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 40 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,087,000 | -13.6% | 865,923 | 0.0% | 0.06% | +36.6% |
| Q2 2018 | $2,416,000 | -41.3% | 865,923 | 0.0% | 0.04% | -43.8% |
| Q1 2018 | $4,113,000 | -18.5% | 865,923 | 0.0% | 0.07% | -15.1% |
| Q4 2017 | $5,048,000 | +177.7% | 865,923 | 0.0% | 0.09% | +186.7% |
| Q3 2017 | $1,818,000 | -55.1% | 865,923 | 0.0% | 0.03% | -51.6% |
| Q2 2017 | $4,053,000 | -40.2% | 865,923 | 0.0% | 0.06% | -52.7% |
| Q1 2017 | $6,772,000 | -36.2% | 865,923 | 0.0% | 0.13% | -44.7% |
| Q4 2016 | $10,616,000 | -10.8% | 865,923 | +13.4% | 0.24% | -2.5% |
| Q3 2016 | $11,907,000 | – | 763,790 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |